FDA approves roflumilast foam 0.3% for scalp, body psoriasis ...

Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months. Maternal consumption of avocado during pregnancy was associated with ...

In this video interview, Jenna Marcovitz, MA, MT-BC, CCLS, RMT, provides insight to music therapy and how it can benefit a wide range of pediatric patients. In this video interview, Jenna Marcovitz, ...

Our editor-in-chief Tina Tan, MD, reacts to a new FDA COVID-19 framework that will limit eligibility for seasonal vaccination in pediatrics. "Unfortunately, that basically does eliminate access of ...

Most videos on TikTok regarding hormonal contraception were misleading, according to a study presented at the 2025 ACOG Annual Clinical and Scientific Meeting. Millions turn to TikTok for health ...

Delandistrogene moxeparvovec-rokl (ELEVIDYS) showed significant motor function improvements in 8- to 9-year-old Duchenne muscular dystrophy patients in part 2 of the phase 3 EMBARK study. In part 2 of ...

Colleen Sloan, PA-C, RDN, highlights what she is seeing in practice related to screen time, devices, and social media and impacts on nutrition. Colleen Sloan, PA-C, RDN, registered dietitian in ...

Zhang Meng shares how advancements in technology have helped prevent early cavities in childhood, and how to counsel your young patients on good oral health. Technology is king these days, starting at ...

Severe RSV disease in 2022–2023 was most likely to occur in infants under 6 months and older children with pulmonary or neurologic conditions. Infants younger than 6 months and premature babies had ...

NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes. Approval was based on phase 3 trials showing strong ...

On May 12, 2025, the FDA cleared an investigational new drug application for Ensoma's lead program EN-374 in X-linked chronic granulomatous disease (X-CGD), according to a press release from genomic ...

"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study ...